Agenda for the December 2022 PBAC intracycle meeting

2 December 2022 - The agenda for the December 2022 PBAC intracycle meeting is now available. ...

Read more →

ICER publishes evidence report on fezolinetant for vasomotor symptoms associated with menopause

1 December 2022 - Evidence is rated as promising but inconclusive to determine whether fezolinetant provides a net health benefit for ...

Read more →

Outcome in relation to discussion of COVID-19 oral treatments – November 2022 PBAC meeting

24 November 2022 - A PBAC outcome in relation to discussion of COVID-19 oral treatments at the November 2022 meeting has ...

Read more →

MSAC Secretariat publishes agenda for March 2023 MSAC meeting

23 November 2022 - The MSAC Secretariat has published a list of applications scheduled to be considered by the MSAC ...

Read more →

Agenda for the March 2023 PBAC meeting

23 November 2022 - The agenda for the March 2023 PBAC meeting is now available. ...

Read more →

PBAC Public Summary Document (November 2022)

18 November 2022 - The Public Summary Documents for the Review of the base-case discount rate in the PBAC Guidelines from ...

Read more →

Public Summary Documents – September 2022 PBAC meeting

11 November 2022 - The Public Summary Document for tixagevimab and cilgavimab (Evusheld) from the September 2022 PBAC intracycle meeting is ...

Read more →

CADTH launches consultation on real world evidence reporting guidance

10 November 2022 - Today, CADTH, on behalf of the Real World Evidence Steering Committee, launched a public consultation to ...

Read more →

Public Summary Documents (first time decisions not to recommend and deferrals) - July 2022 PBAC meeting

11 November 2022 - The Public Summary Documents (first time decisions not to recommend and deferrals) from the July 2022 PBAC ...

Read more →

FDA finalises umbrella trial guidance for cell and gene therapies

4 November 2022 - The US FDA laid out its recommendations for sponsors to study multiple versions of a cellular or ...

Read more →

Outcome statement - September 2022 DUSC meeting

3 November 2022 - The outcome statement from the September 2022 DUSC meeting is now available. ...

Read more →

ICER publishes evidence report on gene therapies for haemophilia A and B

2 November 2022 - Duration of benefit with gene therapies and risks for rare side effects remain major uncertainties. ...

Read more →

Department of Health tweaks the agenda for this week's PBAC meeting

28 October 2022 - The is one late change to the agenda for the November meeting. ...

Read more →

Public Summary Documents – July 2022 PBAC meeting

28 October 2022 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the July 2022 PBAC ...

Read more →

MSAC Secretariat tweaks the agenda for Dec 2022 PASC meeting

26 October 2022 - The PASC will consider one more application. ...

Read more →